143 related articles for article (PubMed ID: 34837271)
1. Plasmapheresis as a promising treatment option in apalutamide-associated toxic epidermal necrolysis.
Miyagawa A; Adachi T; Kobayashi Y; Takamiyagi S; Arakawa H; Futatsugi K; Inazumi T
J Dermatol; 2022 Mar; 49(3):e102-e103. PubMed ID: 34837271
[No Abstract] [Full Text] [Related]
2. Toxic Epidermal Necrolysis Caused by Apalutamide: A Case Report of Treatment Using Etanercept with Conventional Steroid Therapy.
Osawa K; Kiniwa Y; Shimosato Y; Midorikawa H; Shirai T; Sano T; Nakamura K; Okuyama R
Acta Derm Venereol; 2022 May; 102():adv00723. PubMed ID: 35578821
[No Abstract] [Full Text] [Related]
3. Drug reaction with eosinophilia and systemic symptoms with features resembling Stevens-Johnson syndrome/toxic epidermal necrolysis related to apalutamide.
Hsu YO; Hsieh TS; Huang PW; Chu CY
J Eur Acad Dermatol Venereol; 2023 Feb; 37(2):e246-e248. PubMed ID: 36223304
[No Abstract] [Full Text] [Related]
4. Fatal case of toxic epidermal necrolysis due to apalutamide used as a novel prostate cancer drug.
Endo Y; Oka A; Uehara A; Toki S; Motegi SI; Ishikawa O; Miyazawa Y; Suzuki K
J Dermatol; 2020 Oct; 47(10):e359-e360. PubMed ID: 32662533
[No Abstract] [Full Text] [Related]
5. A 2-year-old girl with Stevens--Johnson syndrome/toxic epidermal necrolysis treated with intravenous immunoglobulin.
Arca E; Köse O; Erbil AH; Nişanci M; Akar A; Gür AR
Pediatr Dermatol; 2005; 22(4):317-20. PubMed ID: 16060867
[TBL] [Abstract][Full Text] [Related]
6. Toxic epidermal necrolysis in a patient with psoriatic arthritis.
Pace J; Adami JZ; Mallia C; Mizzi A
Adv Exp Med Biol; 1999; 455():557-60. PubMed ID: 10599399
[No Abstract] [Full Text] [Related]
7. Comparison of reporting of Stevens-Johnson syndrome and toxic epidermal necrolysis in association with selective COX-2 inhibitors.
La Grenade L; Lee L; Weaver J; Bonnel R; Karwoski C; Governale L; Brinker A
Drug Saf; 2005; 28(10):917-24. PubMed ID: 16180941
[TBL] [Abstract][Full Text] [Related]
8. Correlations between clinical patterns and causes of erythema multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis: results of an international prospective study.
Auquier-Dunant A; Mockenhaupt M; Naldi L; Correia O; Schröder W; Roujeau JC;
Arch Dermatol; 2002 Aug; 138(8):1019-24. PubMed ID: 12164739
[TBL] [Abstract][Full Text] [Related]
9. Case report: Apalutamide-induced severe lethal cutaneous adverse effects in China.
Wang Q; Cao H; Zhang X; Wu H; Tang Z
Front Immunol; 2023; 14():1291564. PubMed ID: 38274795
[TBL] [Abstract][Full Text] [Related]
10. Assessing carbamazepine and oxcarbazepine-associated Stevens-Johnson syndrome/toxic epidermal necrolysis: Data mining the public version of the FDA adverse event reporting system.
Xu C; Pan L; Zhang Y; Zhang J; Sun Q; Fang W
Int J Clin Pract; 2021 Aug; 75(8):e14273. PubMed ID: 33908133
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness, safety and tolerability of cyclosporine versus supportive treatment in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: A record-based study.
Mohanty S; Das A; Ghosh A; Sil A; Gharami RC; Bandyopadhyay D; Das NK
Indian J Dermatol Venereol Leprol; 2017; 83(3):312-316. PubMed ID: 28366923
[TBL] [Abstract][Full Text] [Related]
12. [Use of intravenous immunoglobulin in toxic epidermal necrolysis and Stevens-Johnson syndrome].
Kühn-Córdova I; Ramírez-Bouchan D; Gamboa-Marrufo JD
An Pediatr (Barc); 2007 Jul; 67(1):68-73. PubMed ID: 17663910
[TBL] [Abstract][Full Text] [Related]
13. Retrospective analysis of Stevens-Johnson syndrome and toxic epidermal necrolysis in 87 Japanese patients--Treatment and outcome.
Yamane Y; Matsukura S; Watanabe Y; Yamaguchi Y; Nakamura K; Kambara T; Ikezawa Z; Aihara M
Allergol Int; 2016 Jan; 65(1):74-81. PubMed ID: 26666483
[TBL] [Abstract][Full Text] [Related]
14. Stevens-Johnson syndrome and toxic epidermal necrolysis at the University Hospital of the West Indies, Jamaica.
East-Innis AD; Thompson DS
West Indian Med J; 2013 Sep; 62(7):589-92. PubMed ID: 24831894
[TBL] [Abstract][Full Text] [Related]
15. Management of ocular conditions in the burn unit: thermal and chemical burns and Stevens-Johnson syndrome/toxic epidermal necrolysis.
Lin A; Patel N; Yoo D; DeMartelaere S; Bouchard C
J Burn Care Res; 2011; 32(5):547-60. PubMed ID: 21799437
[TBL] [Abstract][Full Text] [Related]
16. RF - Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Treatment Update.
de Quintana-Sancho A; Rubio-Lombraña M; Guergue Díaz-de-Cerio O; Barrutia-Borque A
Actas Dermosifiliogr; 2016 Apr; 107(3):247-8. PubMed ID: 26138285
[No Abstract] [Full Text] [Related]
17. Intravenous immune globulin therapy for Stevens-Johnson syndrome/toxic epidermal necrolysis complicated by hemolysis leading to pigment nephropathy and hemodialysis.
Ririe MR; Blaylock RC; Morris SE; Jung JY
J Am Acad Dermatol; 2013 Aug; 69(2):221-5. PubMed ID: 23673282
[TBL] [Abstract][Full Text] [Related]
18. Novel complication of Flakka: Stevens-Johnson syndrome/Toxic epidermal necrolysis overlap.
İlhan B; Doğan H; Şahin EA; Karslıoğlu N; Koçak Ö
Am J Emerg Med; 2019 Mar; 37(3):562.e1-562.e3. PubMed ID: 30503281
[TBL] [Abstract][Full Text] [Related]
19. Intravenous cyclosporine in treatment of Stevens-Johnson syndrome/toxic epidermal necrolysis: A case series.
Vinay K; Kaushik A; Kumaran MS; Parsad D
Dermatol Ther; 2019 Jul; 32(4):e12957. PubMed ID: 31070856
[No Abstract] [Full Text] [Related]
20. Carbamazepine-Induced Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis Overlap Treated Successfully with Oral Cyclosporin: Case report and literature review.
Al Rajaibi R; Al Rumhi T; Al Abri AM
Sultan Qaboos Univ Med J; 2021 Aug; 21(3):491-494. PubMed ID: 34522420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
